Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 OmicronThe SARS-CoV-2 Omicron variant with increased fitness is spreading rapidly worldwide. Analysis of cryo-EM structures of the spike (S) from Omicron reveals amino acid substitutions forging interactions that stably maintain an active conformation for receptor recognition. The relatively more compact domain organization confers improved stability and enhances attachment but compromises the efficiency of the viral fusion step. Alterations in local conformation, charge, and hydrophobic microenvironments underpin the modulation of the epitopes such that they are not recognized by most NTD- and RBD-antibodies, facilitating viral immune escape. Structure of the Omicron S bound with human ACE2, together with the analysis of sequence conservation in ACE2 binding region of 25 sarbecovirus members, as well as heatmaps of the immunogenic sites and their corresponding mutational frequencies, sheds light on conserved and structurally restrained regions that can be used for the development of broad-spectrum vaccines and therapeutics.
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibodyThe coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in an unprecedented public health crisis. There are no approved vaccines or therapeutics for treating COVID-19. Here we report a humanized monoclonal antibody, H014, that efficiently neutralizes SARS-CoV-2 and SARS-CoV pseudoviruses as well as authentic SARS-CoV-2 at nanomolar concentrations by engaging the spike (S) receptor binding domain (RBD). H014 administration reduced SARS-CoV-2 titers in infected lungs and prevented pulmonary pathology in a human angiotensin-converting enzyme 2 mouse model. Cryo-electron microscopy characterization of the SARS-CoV-2 S trimer in complex with the H014 Fab fragment unveiled a previously uncharacterized conformational epitope, which was only accessible when the RBD was in an open conformation. Biochemical, cellular, virological, and structural studies demonstrated that H014 prevents attachment of SARS-CoV-2 to its host cell receptors. Epitope analysis of available neutralizing antibodies against SARS-CoV and SARS-CoV-2 uncovered broad cross-protective epitopes. Our results highlight a key role for antibody-based therapeutic interventions in the treatment of COVID-19.
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants. Here we examined whether sera from individuals who received two or three doses of inactivated SARS-CoV-2 vaccine could neutralize authentic Omicron. The seroconversion rates of neutralizing antibodies were 3.3% (2 out of 60) and 95% (57 out of 60) for individuals who had received 2 and 3 doses of vaccine, respectively. For recipients of three vaccine doses, the geometric mean neutralization antibody titre for Omicron was 16.5-fold lower than for the ancestral virus (254). We isolated 323 human monoclonal antibodies derived from memory B cells in triple vaccinees, half of which recognized the receptor-binding domain, and showed that a subset (24 out of 163) potently neutralized all SARS-CoV-2 variants of concern, including Omicron. Therapeutic treatments with representative broadly neutralizing monoclonal antibodies were highly protective against infection of mice with SARS-CoV-2 Beta (B.1.351) and Omicron. Atomic structures of the Omicron spike protein in complex with three classes of antibodies that were active against all five variants of concern defined the binding and neutralizing determinants and revealed a key antibody escape site, G446S, that confers greater resistance to a class of antibodies that bind on the right shoulder of the receptor-binding domain by altering local conformation at the binding interface. Our results rationalize the use of three-dose immunization regimens and suggest that the fundamental epitopes revealed by these broadly ultrapotent antibodies are rational targets for a universal sarbecovirus vaccine.
Structure-based development of human antibody cocktails against SARS-CoV-2Nan Wang, Yao Sun, Rui Feng et al.|Cell Research|2020 Land use as an important indicator for water quality prediction in a region under rapid urbanizationSiyang Yao, Cheng Chen, Mengnan He et al.|Ecological Indicators|2022 Land use and land cover (LULC) have significant impacts on river water quality, particularly in regions subjected to rapid urbanization. However, it is unclear whether LULC (LULC type and pattern index) can be used as an effective indicator to predict water quality over the rapid urbanization regions. Here, we investigated the spatiotemporal changes of LULC and their impacts on the water quality of a river flowing through a rapidly developed area in China. Then, a cellular automata-Markov model was established to predict the LULC, which was used as a key indicator to predict future water quality by a multiple linear regression model. The results showed that construction land experienced rapid growth between 2000 and 2010 taking over arable land to a great extent, and the number of patch (NP) showed a significant downward trend during 2000–2010. The biochemical oxygen demand in five days (BOD5), total nitrogen (TN), and total phosphorus (TP) exhibited significantly positive correlations with construction land, while dissolved oxygen (DO) showed a significantly negative correlation with construction land. The DO exhibited a significantly positive correlation with the number of patch (NP), but TN and TP showed significantly negative correlations with NP. The water quality prediction model based on LULC performed well, especially TN prediction has a coefficient of determination of 0.691 and a mean relative error of 12.14%. The prediction of water quality in 2030 indicated that TN will not increase further, but TP will exhibit a remarkable increase in Zhenjiang city if the current development trend continues and no extra pollution control measures are taken.